Halloween has come and gone in the US, and Americans are now gearing up for Thanksgiving and Christmas. But before the holiday season could get underway, the country went through a major political event with far-reaching implications: the midterm elections.As…
BUSINESS
Ono, Novartis Gain Approval of One-Step Titration Regimen for AD Drug Rivastigmine
Ono Pharmaceutical and Novartis Pharma said on August 24 that their Alzheimer’s disease (AD) treatment rivastigmine (Ono: Rivastach Patch; Novartis: Exelon Patch) has obtained approval for a one-step titration regimen that makes it possible to reduce the period from initial…
To read the full story
BUSINESS
- Nipro Eyes 50-60 Stemirac Treatment Sites across Japan after Full Nod
November 20, 2026
- AstraZeneca’s Etcamah to Hit Japan Market on Nov. 27
November 20, 2026
- Japan Drug Makers’ Sales Seen Dipping in FY2026 on Co-Marketing Exits
November 20, 2026
- J&J’s Icotyde Could Broaden Psoriasis Treatment Options: Expert
November 20, 2026
- Nippon Kayaku to Acquire AstraZeneca’s Zoladex on Dec. 16
November 20, 2026





